| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Prasugrel Hydrochloride | FAERS: 28 | US FAERS | |
| 2 | Clopidogrel | FAERS: 13 | US FAERS | |
| 3 | Rosiglitazone | FAERS: 7 | US FAERS | |
| 4 | Ticagrelor | FAERS: 3 | US FAERS | |
| 5 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 | US FAERS | |
| 6 | NuvaRing | FAERS: 2 | US FAERS | |
| 7 | Prasugrel Hydrochloride | FAERS: 2 | US FAERS | |
| 8 | Acitretin | FAERS: 1 | US FAERS | |
| 9 | Bosentan | FAERS: 1 | US FAERS | |
| 10 | Everolimus | FAERS: 1 | US FAERS | |
| 11 | Omeprazole | FAERS: 1 | US FAERS | |
| 12 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 13 | bivalirudin | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.